EMAIL THIS PAGE TO A FRIEND

Journal of pharmaceutical and biomedical analysis

Determination of plasma protein binding of positron emission tomography radioligands by high-performance frontal analysis.


PMID 24922085

Abstract

Positron emission tomography (PET) is an imaging technique based on the use of radioligands labeled with short lived radionuclides, such as (11)C (t½=20.4min) and (18)F (t½=109.8min), which as a consequence often requires rapid plasma protein binding analysis methods. In addition, PET radioligands can suffer from non-specific binding to the membrane when ultrafiltraion, which is the most commonly used method for measuring protein binding in PET, is employed. In this study a high-performance frontal analysis (HPFA) method based on incorporation of a gel filtration column (discovery(®) BIO GFC 100, 50mm×4.6mm, 5μm, 100Å) into a radio-LC system with phosphate buffered saline (PBS, pH 7.4) at a flow rate of 3ml/min as mobile phase was developed and investigated for four PET radioligands. The minimum injection volume (MIV) of plasma, which is a crucial factor in HPFA, was determined to be 200μl (human), 500μl (monkey), 700μl (human) and 1000μl (monkey) for these four radioligands. The MIV values increased as a higher fraction of the radioligand was present in the protein-free form. The protein binding results obtained were in good agreement with ultrafiltration and the method did not suffer from non-specific binding. The short analysis time (<12min) allowed multiple protein binding measurements during time course of a human [(11)C]PBR28 PET study.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

58221
ISA (ionic strength adjustment solution: 1 M KCl), 1 M KCl
ClK
1551139
Monobasic potassium phosphate, United States Pharmacopeia (USP) Reference Standard
H2KO4P
PHR1330
Monobasic Potassium Phosphate, Pharmaceutical Secondary Standard; Certified Reference Material
H2KO4P
38364
Phosphate Standard for IC, TraceCERT®, 1000 mg/L phosphate in water
HNa2O4P
793590
Potassium chloride, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%
ClK
60126
Potassium chloride, tested according to Ph.Eur.
ClK
PHR1329
Potassium Chloride, Pharmaceutical Secondary Standard; Certified Reference Material
ClK
60137 Potassium chloride solution, for Ag/AgCl electrodes, ~3 M KCl
ClK
60135
Potassium chloride solution, BioUltra, ~3 M in H2O
ClK
60134
Potassium chloride solution, conductance standard A acc. to ISO 7888, 0.1 M KCl
ClK
60136
Potassium chloride solution, conductance standard B acc. to ISO 7888, 0.01 M KCl
ClK
60138
Potassium chloride solution, conductance standard C acc. to ISO 7888, 0.001 M KCl
ClK
60229
Potassium phosphate monobasic, tested according to Ph.Eur., anhydrous
H2KO4P
S7907
Sodium phosphate dibasic, BioXtra, ≥99.0%
HNa2O4P
S3264
Sodium phosphate dibasic, for molecular biology, ≥98.5% (titration)
HNa2O4P
S5136
Sodium phosphate dibasic, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99.0%
HNa2O4P
255793
Sodium phosphate dibasic, 99.95% trace metals basis
HNa2O4P
S9763
Sodium phosphate dibasic, ACS reagent, ≥99.0%
HNa2O4P
S0876
Sodium phosphate dibasic, ReagentPlus®, ≥99.0%
HNa2O4P
71636
Sodium phosphate dibasic, BioUltra, for molecular biology, ≥99.5% (T)
HNa2O4P
71639
Sodium phosphate dibasic, BioUltra, anhydrous, ≥99.5% (T)
HNa2O4P
71640
Sodium phosphate dibasic, puriss. p.a., ACS reagent, anhydrous, ≥99.0% (T)
HNa2O4P
04276
Sodium phosphate dibasic, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E 339, anhydrous, 98-100.5% (calc. to the dried substance)
HNa2O4P
71642
Sodium phosphate dibasic, purum p.a., anhydrous, ≥98.0% (T)
HNa2O4P
W239901
Sodium phosphate dibasic, 99%, FG
HNa2O4P
94046
Sodium phosphate dibasic solution, BioUltra, 0.5 M in H2O
HNa2O4P